title: Effect of a sequential therapy of bosentan and iloprost versus a monotherapy with bosentan in the treatment of scleroderma related digital ulcers.
authors.forename: F
authors.initials: F
authors.lastname: Hafner
authors.forename: G
authors.initials: G
authors.lastname: Thomas
authors.forename: H
authors.initials: H
authors.lastname: Froehlich
authors.forename: K
authors.initials: K
authors.lastname: Steidl
authors.forename: M
authors.initials: M
authors.lastname: Brodmann
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000077300:Bosentan; D004359:Drug Therapy, Combination; D005260:Female; D005385:Fingers; D006801:Humans; D016285:Iloprost / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012595:Scleroderma, Systemic / Q000150:complications*; D012883:Skin Ulcer / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D013449:Sulfonamides / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage*; D014945:Wound Healing / Q000187:drug effects*; D055815:Young Adult
chemical_list: D013449:Sulfonamides; D014665:Vasodilator Agents; D016285:Iloprost; D000077300:Bosentan